February 2019 

- Spotlight on Knee - 

The past 20 years of development in knee replacement have led to increased durability and clinical longevity while reducing early complications and surgical time. Here's what to expect in the future of knee replacement from advances in design, manufacturing and surgical tools.

We estimate that the knee replacement market grew to just under $9 billion in 2018, a 3.1% increase vs. 2017, and we expect this segment to remain a steady performer.

We highlight companies that have bolstered their knee lines with these launches from the past 12 months. Robotic assistance technologies, among other factors, are expected to support growth in 2019. Global knee joint reconstruction revenue is estimated to approach $10.5BB in 2022. 


What should device companies and vendors consider when attempting to grow their business with providers? Patrick Vega (Vega Healthcare) provides his expertise in addition to insights from three thought-leaders.

Current Concepts in Joint Replacement's success is attributed to Founder and Course Director A. Seth Greenwald, DPhil(Oxon), a scientist and educator who, after a successful career in aeronautics, stumbled into orthopedics and made a lasting mark on the industry.

  March 12-16  |  Las Vegas

I share 10 companies with you that have never exhibited at AAOS...perhaps they are your newest competitor, acquisition target, provider or customer.

Also at AAOS:
Ali Madani, longtime ORTHOWORLD Member and Founder & Managing Partner at AVICENNE Consulting, will deliver a two-hour tutorial about orthopedic market perspectives and the dynamics impacting the device company/contract manufacturer relationship.  Learn more and register.

Our home base on the exhibit floor is booth #659. If you've never visited, please do. We always have a comfortable seat, a cold drink and an ear for your challenges!

M6-C, developed by Spinal Kinetics, was acquired by OFIX in 2018. The device received CE Mark approval in 2006 and has been implanted more than 45,000 times since then, outside of the U.S.
ARVIS features a standalone surgical headset that projects virtual models of the patient's anatomy into the surgeon's field of view during the procedure. The system provides an alternative to larger, more expensive surgical robots and navigation systems.
KICVentures seeks funding to prepare its spine portfolio companies to be acquisition targets in the next three to five years. Assets include AxioMed Freedomâ„¢ cervical and lumbar disc replacements and NanoFUSE bioactive glass.
The company's ROSA Knee, which received FDA 510(k) clearance in January, will enter limited launch in the first half of 2019 and will be featured at the upcoming AAOS conference.